BCAS3
Gene Information
- Official Symbol: BCAS3
- Official Name: BCAS3 microtubule associated cell migration factor
- Aliases and Previous Symbols: N/A
- Entrez ID: 54828
- UniProt: Q9H6U6
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: N/A
Pfam Domains GO Terms
Pfam Domains
| BCAS3 |
GO Terms
| acetyltransferase activator activity |
| cellular response to estrogen stimulus |
| negative regulation of focal adhesion assembly |
| positive regulation of actin cytoskeleton reorganization |
| regulation of establishment of cell polarity |
| negative regulation of adherens junction organization |
| negative regulation of cell junction assembly |
| regulation of establishment or maintenance of cell polarity |
| transcriptionally active chromatin |
| nuclear hormone receptor binding |
| histone acetyltransferase binding |
| positive regulation of filopodium assembly |
| regulation of actin cytoskeleton reorganization |
| negative regulation of cell-matrix adhesion |
| beta-tubulin binding |
| cell periphery |
| cell leading edge |
| regulation of filopodium assembly |
| negative regulation of GTPase activity |
| intermediate filament cytoskeleton |
| cytoplasmic microtubule |
| regulation of focal adhesion assembly |
| regulation of cell-substrate junction assembly |
| negative regulation of cell-substrate adhesion |
| regulation of adherens junction organization |
| response to estrogen |
| regulation of cell junction assembly |
| microtubule organizing center organization |
| activation of GTPase activity |
| positive regulation of endothelial cell migration |
| positive regulation of plasma membrane bounded cell projection assembly |
| regulation of cell-matrix adhesion |
| histone binding |
| Golgi organization |
| positive regulation of epithelial cell migration |
| tube formation |
| positive regulation of intracellular protein transport |
| regulation of endothelial cell migration |
| response to starvation |
| regulation of plasma membrane bounded cell projection assembly |
| regulation of cell projection assembly |
| positive regulation of intracellular transport |
| regulation of cell-substrate adhesion |
| regulation of epithelial cell migration |
| positive regulation of cytoskeleton organization |
| regulation of intracellular protein transport |
| negative regulation of cell adhesion |
| angiogenesis |
| positive regulation of cellular protein localization |
| transcription factor binding |
| regulation of actin cytoskeleton organization |
| regulation of intracellular transport |
| positive regulation of cell projection organization |
| regulation of actin filament-based process |
| chromatin binding |
| blood vessel morphogenesis |
| positive regulation of GTPase activity |
| endomembrane system organization |
| positive regulation of protein transport |
| negative regulation of hydrolase activity |
| positive regulation of establishment of protein localization |
| microtubule cytoskeleton organization |
| regulation of GTPase activity |
| blood vessel development |
| response to nutrient levels |
| positive regulation of cell migration |
| vasculature development |
| cardiovascular system development |
| positive regulation of cellular component biogenesis |
| positive regulation of cell motility |
| response to extracellular stimulus |
| positive regulation of cellular component movement |
| regulation of cellular protein localization |
| regulation of cytoskeleton organization |
| positive regulation of locomotion |
| positive regulation of organelle organization |
| tube morphogenesis |
| microtubule-based process |
| regulation of cell adhesion |
| regulation of plasma membrane bounded cell projection organization |
| negative regulation of cellular component organization |
| regulation of protein transport |
| regulation of cell projection organization |
| regulation of peptide transport |
| regulation of establishment of protein localization |
| positive regulation of hydrolase activity |
| negative regulation of catalytic activity |
| tube development |
| regulation of cell migration |
| nucleolus |
| circulatory system development |
| anatomical structure formation involved in morphogenesis |
| regulation of cell motility |
| regulation of cellular localization |
| regulation of cellular component biogenesis |
| regulation of locomotion |
| positive regulation of transport |
| regulation of cellular component movement |
| regulation of protein localization |
| cytoskeleton organization |
| negative regulation of molecular function |
| positive regulation of cellular component organization |
| positive regulation of transcription by RNA polymerase II |
| regulation of hydrolase activity |
| regulation of organelle organization |
| positive regulation of catalytic activity |
| positive regulation of transcription, DNA-templated |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| positive regulation of RNA metabolic process |
| positive regulation of multicellular organismal process |
| positive regulation of molecular function |
| regulation of transport |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| positive regulation of biosynthetic process |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
| Screen | Score |
|---|---|
| Asunaprenir 3μM R07 exp336 | -1.91 |
| BI-D1870 2μM R04 exp162 | 2.31 |
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| PRIM1 | 0.425 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 1/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 1/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 18006
- Expression level (log2 read counts): 3.78
Expression Distribution
BCAS3 Expression in NALM6 Cells: 3.78